Pioglitazone: update on an oral antidiabetic drug with antiatherosclerotic effects.
Pfützner, Andreas
Pioglitazone: update on an oral antidiabetic drug with antiatherosclerotic effects. [electronic resource] - Expert opinion on pharmacotherapy Aug 2007 - 1985-98 p. digital
Publication Type: Journal Article; Review
1744-7666
10.1517/14656566.8.12.1985 doi
Atherosclerosis--prevention & control
Cardiovascular Diseases--drug therapy
Diabetes Mellitus, Type 2--drug therapy
Drug Therapy, Combination
Fatty Liver--drug therapy
Humans
Hypoglycemic Agents--adverse effects
PPAR gamma--agonists
Pioglitazone
Randomized Controlled Trials as Topic
Thiazolidinediones--adverse effects
Pioglitazone: update on an oral antidiabetic drug with antiatherosclerotic effects. [electronic resource] - Expert opinion on pharmacotherapy Aug 2007 - 1985-98 p. digital
Publication Type: Journal Article; Review
1744-7666
10.1517/14656566.8.12.1985 doi
Atherosclerosis--prevention & control
Cardiovascular Diseases--drug therapy
Diabetes Mellitus, Type 2--drug therapy
Drug Therapy, Combination
Fatty Liver--drug therapy
Humans
Hypoglycemic Agents--adverse effects
PPAR gamma--agonists
Pioglitazone
Randomized Controlled Trials as Topic
Thiazolidinediones--adverse effects